These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation. Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275 [TBL] [Abstract][Full Text] [Related]
23. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation. Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126 [TBL] [Abstract][Full Text] [Related]
24. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines. van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925 [TBL] [Abstract][Full Text] [Related]
26. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells. Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674 [TBL] [Abstract][Full Text] [Related]
27. Hematopoietic origin of human natural killer (NK) cells: generation from immature progenitors. Silva MR; Kessler S; Ascensao JL Pathobiology; 1993; 61(5-6):247-55. PubMed ID: 7507682 [TBL] [Abstract][Full Text] [Related]
28. Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD/SCID/IL-2Rγc null mice. Thomas S; Klobuch S; Sommer M; van Ewijk R; Theobald M; Meyer RG; Herr W Exp Hematol; 2014 Jan; 42(1):28-38.e1-2. PubMed ID: 24120693 [TBL] [Abstract][Full Text] [Related]
29. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals. Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286 [TBL] [Abstract][Full Text] [Related]
30. Cyclosporine inhibits the development of green fluorescent protein (GFP)-specific immune responses after transplantation of GFP-expressing hematopoietic repopulating cells in dogs. Beagles KE; Peterson L; Zhang X; Morris J; Kiem HP Hum Gene Ther; 2005 Jun; 16(6):725-33. PubMed ID: 15960603 [TBL] [Abstract][Full Text] [Related]
31. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood. Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284 [TBL] [Abstract][Full Text] [Related]
32. Long-term immune recovery after CD34+ immunoselected and unselected peripheral blood progenitor cell transplantation: a case-control study. Laurenti L; Sica S; Sorà F; Piccirillo N; Ortu La Barbera E; Chiusolo P; Salutari P; Rumi C; Rutella S; Leone G Haematologica; 1999 Dec; 84(12):1100-3. PubMed ID: 10586212 [TBL] [Abstract][Full Text] [Related]
33. Rejection of bone marrow cells by irradiated mice: NK and T cells recognize different antigens. Bennett M; Kumar V; Mikhael A; Murphy WJ; Rembecki RM; Sentman CL; David CS Transplant Proc; 1987 Dec; 19(6 Suppl 7):5-11. PubMed ID: 3321646 [No Abstract] [Full Text] [Related]
34. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures. Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732 [TBL] [Abstract][Full Text] [Related]
35. T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect. Cruz CR; Bollard CM Haematologica; 2015 Jun; 100(6):709-19. PubMed ID: 26034113 [TBL] [Abstract][Full Text] [Related]
37. Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cells. Cui Y; Kelleher E; Straley E; Fuchs E; Gorski K; Levitsky H; Borrello I; Civin CI; Schoenberger SP; Cheng L; Pardoll DM; Whartenby KA Nat Med; 2003 Jul; 9(7):952-8. PubMed ID: 12778137 [TBL] [Abstract][Full Text] [Related]
38. [The growth of hematopoietic stem cells is inhibited by natural killers only in a non-syngeneic microenvironment]. Petrov RV; Dozmorov IM; Pirozhkov AV Dokl Akad Nauk SSSR; 1988; 299(6):1513-6. PubMed ID: 2901331 [No Abstract] [Full Text] [Related]
39. Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells. Joo SY; Chung YS; Choi B; Kim M; Kim JH; Jun TG; Chang J; Sprent J; Surh CD; Joh JW; Kim SJ Transplantation; 2012 Dec; 94(11):1095-102. PubMed ID: 23222735 [TBL] [Abstract][Full Text] [Related]
40. Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation. Kato S; Ando K; Nakamura Y; Muguruma Y; Sato T; Yabe H; Yabe M; Hattori K; Yasuda Y; Hotta T Bone Marrow Transplant; 2001 Sep; 28(6):587-95. PubMed ID: 11607772 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]